For liver health, a Phase 2a trial in patients with metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as NAFLD) showed extraordinary results
We know how hard it can be to lose weight and get blood sugars under good control
This product is not intended to diagnose, treat, cure or prevent any disease.
What if I told you that you could dose a GLP-1 med once a month and it would allow for weight loss like semaglutide but with perhaps marginally better side effects
Slower Gastric Emptying: GLP-1 medications delay stomach emptying, meaning food stays in the stomach longer
[DOI] [PMC free article] [PubMed] [Google Scholar] 252.Sousa J.R., Afreixo V., Carvalho J., Silva P